Literature DB >> 7777169

The AMPA glutamate receptor GluR3 is enriched in oxytocinergic magnocellular neurons and is localized at synapses.

S D Ginsberg1, D L Price, C D Blackstone, R L Huganir, L J Martin.   

Abstract

The cellular localization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate glutamate receptor, GluR3, was identified using antibodies that recognize the N-terminus of the predicted polypeptide sequence of GluR3. Regional immunoblot analysis of monkey brain homogenates identified a protein of approximately 102,000 mol. wt that was enriched in hypothalamus. Immunocytochemistry demonstrated that GluR3 was enriched within the hypothalamic magnocellular neurosecretory nuclei and axons of the hypothalamo-neurohypophysial tract in rat and monkey. GluR3 immunoreactivity co-localized to oxytocin-containing, but not vasopressin-containing, neurons of the hypothalamic paraventricular nucleus, supraoptic nucleus and accessory magnocellular nuclei. Ultrastructurally, GluR3 immunoreactivity was enriched throughout cytoplasm of the somatodendritic compartment and was associated with postsynaptic and presynaptic structures. GluR3 immunoreactivity was frequently observed to be clustered at the plasma membrane of the somatodendritic compartment, consistent with the predicted localization of a membrane-bound ion channel. Additionally, GluR3-immunoreactive axon terminals in synaptic contact with unlabeled dendrites within the retrochiasmatic area and bed nucleus of the stria terminalis were observed, providing morphological evidence for a presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor. By immunoblot analysis and immunocytochemistry using antibodies directed against a specific alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor in rat and monkey brain, our findings suggest a highly selective hypothalamic distribution of the GluR3 subunit that may have functional significance in the glutamatergic regulation of oxytocinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777169     DOI: 10.1016/0306-4522(94)00513-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

Authors:  Melissa J Alldred; Karen E Duff; Stephen D Ginsberg
Journal:  Neurobiol Dis       Date:  2011-11-07       Impact factor: 5.996

2.  Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury.

Authors:  S K Agrawal; M G Fehlings
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

3.  An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain.

Authors:  Steven R King; Pulak R Manna; Tomohiro Ishii; Peter J Syapin; Stephen D Ginsberg; Kevin Wilson; Lance P Walsh; Keith L Parker; Douglas M Stocco; Roy G Smith; Dolores J Lamb
Journal:  J Neurosci       Date:  2002-12-15       Impact factor: 6.167

4.  Differential effects of glutamate agonists and D-aspartate on oxytocin release from hypothalamus and posterior pituitary of male rats.

Authors:  M Pampillo; M del Carmen Díaz; B H Duvilanski; V Rettori; A Seilicovich; M Lasaga
Journal:  Endocrine       Date:  2001-08       Impact factor: 3.925

Review 5.  AMPA Receptor Function in Hypothalamic Synapses.

Authors:  Maria Royo; Beatriz Aznar Escolano; M Pilar Madrigal; Sandra Jurado
Journal:  Front Synaptic Neurosci       Date:  2022-01-31

6.  A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disability.

Authors:  Benjamin Davies; Laurence A Brown; Ondrej Cais; Jake Watson; Amber J Clayton; Veronica T Chang; Daniel Biggs; Christopher Preece; Polinka Hernandez-Pliego; Jon Krohn; Amarjit Bhomra; Stephen R F Twigg; Andrew Rimmer; Alexander Kanapin; Arjune Sen; Zenobia Zaiwalla; Gil McVean; Russell Foster; Peter Donnelly; Jenny C Taylor; Edward Blair; David Nutt; A Radu Aricescu; Ingo H Greger; Stuart N Peirson; Jonathan Flint; Hilary C Martin
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.